The Precision Cardiology Laboratory (PCL) of the Broad Institute and Bayer will focus on using innovative technologies to better understand cardiovascular disease and pursue new drug targets.
The PCL combines Broad’s innovative methods for basic scientific discovery and the clinical expertise of its practicing physician/researchers with Bayer’s long history of drug discovery and development. Physically located at the Broad, the PCL consists of scientists from the Broad and Bayer working together toward a shared scientific vision.
The initial goal of the PCL is to characterize individual cells from human tissue samples and preclinical animal models in health and disease. These high-resolution, single cell maps will broaden our understanding of underlying disease mechanisms and facilitate the development of new therapeutic interventions.
